表紙
市場調査レポート

MediPoint:冠動脈ステント - 現在および将来の企業

MediPoint: Coronary Stents - Current and Future Players

発行 GlobalData 商品コード 320350
出版日 ページ情報 英文 234 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
MediPoint:冠動脈ステント - 現在および将来の企業 MediPoint: Coronary Stents - Current and Future Players
出版日: 2014年11月28日 ページ情報: 英文 234 Pages
概要

世界の冠動脈ステント市場はダイナミックな2桁市場であり、多くの事業者が革新的な技術の開発を行っています。低侵襲技術の発展を伴う心血管インターベンションの分野の急速な進歩が、応用分野の可能性を大いに拡大しています。メアメタル、薬剤溶出、カバード、生体吸収性などの冠動脈ステントが冠動脈疾患に用いられ、転帰を最適化することが可能です。

当レポートでは、冠動脈ステントの技術開発の動向について調査し、市場形成に影響する各種要因の分析、現在の技術開発の動向、開発中の製品の動向、主要企業の取り組みなどをまとめています。

第1章 目次

第2章 イントロダクション

第3章 競合分析

  • 概要
  • 冠動脈ステントの技術開発動向
    • ベアメタルステントステントの発展
    • 薬剤溶出ステントの発展
    • 生体吸収性ステントの発展
    • カバードステントの発展
    • 冠動脈ステント技術:SWOT分析

第4章 パイプライン製品

  • 概要
  • パイプライン:開発段階別
  • パイプライン製品のプロファイル
    • 生体吸収性ステント
    • その他のタイプの血管ステント

第5章 現在および将来の主要企業

  • 概要
  • 企業戦略の動向
  • 企業プロファイル
    • Abbott Vascular
    • Boston Scientific Corporation
    • Medtronic
    • Alvimedica
    • Amaranth Medical
    • amg International
    • Arterial Remodeling Technologies
    • B. Braun
    • Balton
    • Biosensors International
    • Biotronik
    • Blue Medical
    • Cardionovum
    • C.R.Bard
    • Elixir Medical Corporation
    • eucatech AG
    • Hexacath
    • IRAMED
    • JW Medical Systems
    • 京都医療設計
    • Lepu Medical Technology
    • MicroPort Scientific Corporation
    • Minvasys
    • MIV Therapeutics
    • Opto Circuits
    • OrbusNeich Medical
    • Relisys Medical Devices
    • REVA Medical
    • Sahajanand Medical Technologies
    • STENTYS
    • テルモ
    • Translumina
    • Vascular Concepts
    • その他

第6章 付録

目次
Product Code: GDME1031FPR

The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes.

The coronary stents market is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation.

Scope

  • Investigation of current and future market competition for Coronary Stents.
  • Competitor assessment including device approval analysis.
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice.

Reasons to buy

  • Gain a high level view of the trends shaping and driving the Coronary Stents market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Competitive Assessment

  • 3.1. Overview
  • 3.2. Trends in Coronary Stent Technology Development
    • 3.2.1. Development of Bare Metal Stents
    • 3.2.2. Development of Drug-Eluting Stents
    • 3.2.3. Development of Bioabsorbable Stents
    • 3.2.4. Development of Covered Stents
    • 3.2.5. Coronary Stent Technology SWOT Analysis

4. Pipeline Products

  • 4.1. Overview
  • 4.2. Pipeline by Stage of Development
  • 4.3. Pipeline Product Profiles
    • 4.3.1. Bioabsorbable Stents
    • 4.3.2. Other Types of Vascular Stents

5. Current and Future Players

  • 5.1. Overview
  • 5.2. Trends in Corporate Strategy
  • 5.3. Company Profiles
    • 5.3.1. Abbott Vascular
    • 5.3.2. Boston Scientific Corporation
    • 5.3.3. Medtronic
    • 5.3.4. Alvimedica
    • 5.3.5. Amaranth Medical
    • 5.3.6. amg International
    • 5.3.7. Arterial Remodeling Technologies
    • 5.3.8. B. Braun
    • 5.3.9. Balton
    • 5.3.10. Biosensors International
    • 5.3.11. Biotronik
    • 5.3.12. Blue Medical
    • 5.3.13. Cardionovum
    • 5.3.14. C.R. Bard
    • 5.3.15. Elixir Medical Corporation
    • 5.3.16. eucatech AG
    • 5.3.17. Hexacath
    • 5.3.18. IRAMED
    • 5.3.19. JW Medical Systems
    • 5.3.20. Kyoto Medical Planning
    • 5.3.21. Lepu Medical Technology
    • 5.3.22. MicroPort Scientific Corporation
    • 5.3.23. Minvasys
    • 5.3.24. MIV Therapeutics
    • 5.3.25. Opto Circuits
    • 5.3.26. OrbusNeich Medical
    • 5.3.27. Relisys Medical Devices
    • 5.3.28. REVA Medical
    • 5.3.29. Sahajanand Medical Technologies
    • 5.3.30. STENTYS
    • 5.3.31. Terumo Corporation
    • 5.3.32. Translumina
    • 5.3.33. Vascular Concepts
    • 5.3.34. Other Companies

6. Appendix

  • 6.1. Bibliography
  • 6.2. Abbreviations
  • 6.3. Report Methodology
    • 6.3.1. Overview
    • 6.3.2. Coverage
    • 6.3.3. Secondary Research
  • 6.4. Physicians and Specialists Included in This Study
    • 6.4.1. Praveen Chandra, MD, DM, FESC, FSCAI, FAPSCI
    • 6.4.2. Bernado Cortese, MD, FESC
    • 6.4.3. Ricardo A. Costa, MD
    • 6.4.4. Thomas Cuisset, MD, PhD, FESC
    • 6.4.5. Nobuyuki Komiyama, MD, PhD, FACC, FJCC
    • 6.4.6. Roger J. Laham, MD
    • 6.4.7. Mark W. Mewissen, MD
    • 6.4.8. Gary S. Mintz, MD
    • 6.4.9. Tudor C. Poerner, MD
    • 6.4.10. David Ramsdale, MD, PhD
    • 6.4.11. Gregory A. Sgueglia, MD, PhD
    • 6.4.12. Madhukar Shahi, MD
    • 6.4.13. Takehiro Yamashita, MD, PhD, FACC
  • 6.5. Primary Research
    • 6.5.1. Primary Research - Key Opinion Leader Interviews
    • 6.5.2. Primary Research Interviews- Physician and Industry Participants
    • 6.5.3. Physican Survey
    • 6.5.4. Expert Panel Validation
  • 6.6. Forecasting Methodology
  • 6.7. About the Authors
    • 6.7.1. Analysts
    • 6.7.2. Global Head of Healthcare
  • 6.8. About MediPoint
  • 6.9. About GlobalData
  • 6.10. Disclaimer

List of Tables

  • Table 1: Coronary Stent Technology SWOT Analysis, 2014
  • Table 2: Global Coronary Stent Pipeline Products, 2014
  • Table 3: ART18Z SWOT Analysis, 2014
  • Table 4: DREAMS SWOT Analysis, 2014
  • Table 5: Fantom SWOT Analysis, 2014
  • Table 6: Fortitude SWOT Analysis, 2014
  • Table 7: Ideal BioStent SWOT Analysis, 2014
  • Table 8: Igaki-Tamai Stent SWOT Analysis, 2014
  • Table 9: ON-AVS SWOT Analysis, 2014
  • Table 10: Other Companies Developing BAS, 2014
  • Table 11: FOCUS np Eluting Stent SWOT Analysis, 2014
  • Table 12: STENTYS Sirolimus-Eluting Stent SWOT Analysis, 2014
  • Table 13: Svelte Drug-Eluting Stent SWOT Analysis, 2014
  • Table 14: Abbott Vascular Company Profile
  • Table 15: Abbott Vascular Coronary Stent Marketed Products
  • Table 16: Abbott Vascular Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 17: Abbott Vascular SWOT Analysis, 2014
  • Table 18: Boston Scientific Corporation Company Profile
  • Table 19: Boston Scientific Coronary Stent Marketed Products
  • Table 20: Boston Scientific Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 21: Boston Scientific Corporation SWOT Analysis, 2014
  • Table 22: Medtronic Company Profile
  • Table 23: Medtronic Coronary Stent Marketed Products
  • Table 24: Medtronic Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 25: Medtronic SWOT Analysis, 2014
  • Table 26: Alvimedica Company Profile
  • Table 27: Alvimedica Coronary Stent Marketed Products
  • Table 28: Alvimedica Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 29: Alvimedica SWOT Analysis, 2014
  • Table 30: Amaranth Medical Company Profile
  • Table 31: Amaranth Medical Coronary Stent Pipeline Product
  • Table 32: Amaranth Medical Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 33: Amaranth Medical SWOT Analysis, 2014
  • Table 34: amg International Company Profile
  • Table 35: amg International Coronary Stent Marketed Products
  • Table 36: amg International Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 37: amg International SWOT Analysis, 2014
  • Table 38: Arterial Remodeling Technologies Company Profile
  • Table 39: Arterial Remodeling Technologies Coronary Stent Pipeline Product
  • Table 40: Arterial Remodeling Technologies Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 41: Arterial Remodeling Technologies SWOT Analysis, 2014
  • Table 42: B. Braun Company Profile
  • Table 43: B. Braun Coronary Stent Marketed Products
  • Table 44: B. Braun Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 45: B. Braun SWOT Analysis, 2014
  • Table 46: Balton Company Profile
  • Table 47: Balton Coronary Stent Marketed Products
  • Table 48: BALTON Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 49: Balton SWOT Analysis, 2014
  • Table 50: Biosensors International Company Profile
  • Table 51: Biosensors International Coronary Stent Marketed Products
  • Table 52: Biosensors International Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 53: Biosensors International SWOT Analysis, 2014
  • Table 54: Biotronik Company Profile
  • Table 55: Biotronik Coronary Stent Marketed and Pipeline Products
  • Table 56: Biotronik Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 57: Biotronik SWOT Analysis, 2014
  • Table 58: Blue Medical Company Profile
  • Table 59: Blue Medical Coronary Stent Marketed Products
  • Table 60: Blue Medical Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 61: Blue Medical SWOT Analysis, 2014
  • Table 62: Cardionovum Company Profile
  • Table 63: Cardionovum Coronary Stent Marketed and Pipeline Products
  • Table 64: Cardionovum Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 65: Cardionovum SWOT Analysis, 2014
  • Table 66: C.R. Bard Company Profile
  • Table 67: ClearStream Technologies Coronary Stent Marketed Products
  • Table 68: C.R. Bard Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 69: C.R. Bard SWOT Analysis, 2014
  • Table 70: Elixir Medical Corporation Company Profile
  • Table 71: Elixir Medical Corporation Coronary Stent Marketed Products
  • Table 72: Elixir Medical Corporation Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 73: Elixir Medical Corporation SWOT Analysis, 2014
  • Table 74: eucatech Profile
  • Table 75: eucatech Coronary Stent Marketed Products
  • Table 76: eucatech Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 77: eucatech SWOT Analysis, 2014
  • Table 78: Hexacath Company Profile
  • Table 79: Hexacath Coronary Stent Marketed Products
  • Table 80: Hexacath Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 81: Hexacath SWOT Analysis, 2014
  • Table 82: IRAMED Company Profile
  • Table 83: IRAMED Coronary Stent Marketed Products
  • Table 84: IRAMED Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 85: IRAMED SWOT Analysis, 2014
  • Table 86: JW Medical Systems Company Profile
  • Table 87: JW Medical Systems Coronary Stent Marketed Product
  • Table 88: JW Medical Systems' Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 89: JW Medical Systems SWOT Analysis, 2014
  • Table 90: Kyoto Medical Planning Company Profile
  • Table 91: Kyoto Medical Planning Coronary Stent Pipeline Product
  • Table 92: Kyoto Medical Planning Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 93: Kyoto Medical Planning SWOT Analysis, 2014
  • Table 94: Lepu Medical Technology Company Profile
  • Table 95: Lepu Medical Technology Coronary Stent Marketed and Pipeline Products
  • Table 96: Lepu Medical Technology Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 97: Lepu Medical Technology SWOT Analysis, 2014
  • Table 98: MicroPort Scientific Corporation Company Profile
  • Table 99: MicroPort Scientific Corporation Coronary Stent Marketed Products
  • Table 100: MicroPort Scientific Corporation Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 101: MicroPort Scientific Corporation SWOT Analysis, 2014
  • Table 102: Minvasys Company Profile
  • Table 103: Minvasys Coronary Stent Marketed and Pipeline Products
  • Table 104: Minvasys Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 105: Minvasys SWOT Analysis, 2014
  • Table 106: MIV Therapeutics Company Profile
  • Table 107: MIV Therapeutics Coronary Stent Marketed Products
  • Table 108: MIV Therapeutics Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 109: MIV Therapeutics SWOT Analysis, 2014
  • Table 110: Opto Circuits Company Profile
  • Table 111: Opto Circuits Coronary Stent Marketed Products
  • Table 112: Opto Circuits Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 113: Opto Circuits SWOT Analysis, 2014
  • Table 114: OrbusNeich Medical Company Profile
  • Table 115: OrbusNeich Medical Coronary Stent Marketed and Pipeline Products
  • Table 116: OrbusNeich Medical Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 117: OrbusNeich Medical SWOT Analysis, 2014
  • Table 118: Relisys Medical Devices Company Profile
  • Table 119: Relisys Medical Devices Coronary Stent Marketed Products
  • Table 120: Relisys Medical Devices Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 121: Relisys Medical Devices SWOT Analysis, 2014
  • Table 122: REVA Medical Company Profile
  • Table 123: REVA Medical Coronary Stent Pipeline Product
  • Table 124: REVA Medical Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 125: REVA Medical SWOT Analysis, 2014
  • Table 126: Sahajanand Medical Technologies Company Profile
  • Table 127: Sahajanand Medical Technologies Coronary Stent Marketed and Pipeline Products
  • Table 128: Sahajanand Medical Technologies Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 129: Sahajanand Medical Technologies SWOT Analysis, 2014
  • Table 130: STENTYS Company Profile
  • Table 131: STENTYS Coronary Stent Marketed and Pipeline Products
  • Table 132: STENTYS Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 133: STENTYS SWOT Analysis, 2014
  • Table 134: Terumo Corporation Company Profile
  • Table 135: Terumo Corporation Coronary Stent Marketed and Pipeline Products
  • Table 136: Terumo Corporation Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 137: Terumo Corporation SWOT Analysis, 2014
  • Table 138: Translumina Company Profile
  • Table 139: Translumina Coronary Stent Marketed Products
  • Table 140: Translumina Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 141: Translumina SWOT Analysis, 2014
  • Table 142: Vascular Concepts Company Profile
  • Table 143: Vascular Concepts Coronary Stent Marketed Products
  • Table 144: Vascular Concepts Coronary Stent Product Portfolio SWOT Analysis, 2014
  • Table 145: Vascular Concepts SWOT Analysis, 2014
  • Table 146: Other Companies in the Coronary Stent Market, North America, 2014
  • Table 147: Other Companies in the Coronary Stent Market, EU, 2014
  • Table 148: Other Companies in the Coronary Stent Market, APAC, 2014
  • Table 149: Other Companies in the Coronary Stent Market, South Africa and South America, 2014
  • Table 150: Primary Research Interviews Completed
  • Table 151: Physicians Surveyed, By Country

List of Figures

  • Figure 1: Global Coronary Stents Market Value Share (%), 2013 and 2020
  • Figure 2: Global Coronary Stent Pipeline Products by Stage of Development, 2014
Back to Top